Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.61 USD | +2.46% | +9.41% | -9.44% |
May. 07 | Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
May. 07 | Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.11% | 1.9B | |
+29.05% | 48.16B | |
-0.67% | 41.73B | |
+44.64% | 41.03B | |
-5.31% | 28.77B | |
+10.48% | 25.59B | |
-22.47% | 18.96B | |
+8.50% | 12.92B | |
+28.68% | 12.03B | |
-2.57% | 11.77B |
- Stock Market
- Equities
- BEAM Stock
- News Beam Therapeutics Inc.
- RBC Raises Price Target on Beam Therapeutics to $35 From $27 on 'More Favorable Regulatory Environment,' Keeps Sector Perform, Speculative Risk